Skip to main content

Table 6 Failure analysis in P67.5 and P70 study

From: Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas

Failure patterns

Num of patients

Median failure time month (range)

Num of salvage treatment (%)

Num of death (%)

Median time from failure to death month (range)

P67.5

P70

P67.5

P70

P67.5

P70

P67.5

P70

P67.5

P70

Local recurrence

5

6

22.0 (15–29)

12.8 (5–34)

3 (60%)

2 (33%)

3 (60%)

4 (67%)

10.3 (3–18)

4.0 (1–7)

 In-field

3

4

24.3 (21–29)

15.0 (6–34)

2 (66%)

1 (25%)

2 (66%)

3 (75%)

6.5 (3–10)

3.6 (1–7)

 Marginal

2

2

18.5 (15–22)

8.5 (5–12)

1 (50%)

1 (50%)

1 (50%)

1 (50%)

18

5

Reginal recurrence

3

3

25.6 (23–30)

16.7 (10–24)

3 (100%)

3 (100%)

0

2 (67%)

-

12.5 (12–13)

Distant metastasis

10

11

10.9 (4–26)

19.4 (3–38)

5 (50%)

5 (45%)

9 (90%)

9 (82%)

8.3 (3–19)

8.5 (0–35)

 Liver

5

3

14.8 (12–16)

20.3 (3–29)

2 (40%)

0

4 (80%)

3 (100%)

7.5 (3–19)

3.7 (1–5)

 Bone

3

4

6.3 (4–9)

17.5 (3–38)

2 (67%)

2 (50%)

3 (100%)

3 (75%)

9.0 (3–13)

13.7 (0–35)

 Lung

1

0

8

-

1 (100%)

-

1 (100%)

-

13

-

 Multiple or others

1

4

8

20.5 (10–30)

0

3 (75%)

1 (100%)

3 (75%)

5

8.3 (1–17)

Hemorrhage

1

5

10

9.2 (6–12)

0

0

1 (100%)

5 (100%)

0

0

Other patterns

0

1

-

12

-

0

-

1 (100%)

-

0